| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029
The effect of antigen, activation of normal A48Id+ B-cell clones, and monoclonal antibodies sharing A48-UPC10 regulatory idiotopes on the in vivo growth of spleen adapted ABPC48 myeloma cells has been examined. Immunogenic doses of bacterial levan have no detectable effects, whereas tolerogenic doses substantially delay the growth of the myeloma. The activation of normal A48Id+ B cell clones also has no apparent effect on the growth of the ABPC48 myeloma cells. Among a panel of 15 monoclonal antibodies expressing A48-UPC10 regulatory idiotopes and expressing VH genes derived from the VH441-4 germ line gene family, 5 were able to provide a long lasting but not definitive idiotype specific protection against the ABPC48 myeloma cells.
1 Supported by Grant IM-275 from the American Cancer Society.
2 To whom requests for reprints should be addressed, at Annenberg 1660, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029.
Received 6/11/85. Revised 10/25/85. Accepted 12/11/85.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |